Hyundai Pharmaceutical Co., Ltd. (KRX:004310)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,060.00
+1,165.00 (29.91%)
At close: Dec 5, 2025
30.92%
Market Cap 140.05B
Revenue (ttm) 108.14B
Net Income (ttm) 1.41B
Shares Out 27.68M
EPS (ttm) 60.34
PE Ratio 83.86
Forward PE n/a
Dividend 30.00 (0.77%)
Ex-Dividend Date Mar 4, 2025
Volume 16,827,142
Average Volume 214,516
Open 4,200.00
Previous Close 3,895.00
Day's Range 4,050.00 - 5,060.00
52-Week Range 2,995.00 - 5,060.00
Beta 0.37
RSI 63.20
Earnings Date n/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.